Again, when HCC patients were compared with LC patients, the AUC for thioredoxin was also larger than that for AFP (0.801, 0.767–0.845 vs. 0.703, 0.665–0.763, P = 0.003). This evidence concerns the gene TXN and hepatocellular carcinoma.